Genscript Biotech Corp earnings per share and revenue

GNNSF earnings per share for the last semiannual are -0.03 USD whereas the estimation was -0.05 USD which accounts for 36.00% surprise. Company revenue for the same period amounts to 448.11 M USD despite the estimated figure of 465.70 M USD. Estimated earnings per share for the next semiannual are 0.03 USD, and revenue is expected to reach 645.40 M USD. Also watch annual changes over time to get a bigger picture of GNNSF earnings per share and revenue dynamics.